According to the Zhitong Finance App, China Biopharmaceutical (01177.HK) announced that on October 13, 2026, the company spent HK$395.648 million to repurchase 7.4 million shares at a repurchase price of HK$5.325-5.35 per share.

Zhitongcaijing · 4d ago
According to the Zhitong Finance App, China Biopharmaceutical (01177.HK) announced that on October 13, 2026, the company spent HK$395.648 million to repurchase 7.4 million shares at a repurchase price of HK$5.325-5.35 per share.